← Back to Search

Other

Arm 1: NADA points and digital pressure for Smoking Cessation

Phase 2
Waitlist Available
Led By Lawrence Leung, MD
Research Sponsored by Queen's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly during the intervention period (weeks 1-6) and week 13 and week 26
Awards & highlights

Study Summary

Auricular acupressure has been practiced in China and Germany to help people in smoking cessation programs. The purpose of this clinical trial is to test for the clinical effectiveness of self-administered auricular acupressure as a non-invasive method for smoking cessation.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly during the intervention period (weeks 1-6) and week 13 and week 26
This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly during the intervention period (weeks 1-6) and week 13 and week 26 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Spot 7-day cessation rate
Secondary outcome measures
Adverse effects in terms of self-reported discomfort levels from auricular acupressure
Continuous Cessation Rate (CAR)
End-expiratory carbon monoxide levels (CO)
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Arm 2: random points + digital pressure with urgeExperimental Treatment1 Intervention
Arm 2 (20 participants): random points + digital pressure with urge
Group II: Arm 1: NADA points and digital pressureExperimental Treatment1 Intervention
Arm 1: NADA points and digital pressure with urge.
Group III: Arm 3 (20 participants): NO acupressure, only advice + supportActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Queen's UniversityLead Sponsor
365 Previous Clinical Trials
120,357 Total Patients Enrolled
Lawrence Leung, MDPrincipal InvestigatorQueen's University
1 Previous Clinical Trials
116 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025